AAAAAA

   
Results: 1-12 |
Results: 12

Authors: MARCH JS BIEDERMAN J WOLKOW R SAFFERMAN A MARDEKIAN J COOK EH CUTLER NR DOMINGUEZ R FERGUSON J MULLER B RIESENBERG R ROSENTHAL M SALLEE FR WAGNER KD
Citation: Js. March et al., SERTRALINE IN CHILDREN AND ADOLESCENTS WITH OBSESSIVE-COMPULSIVE DISORDER - A MULTICENTER RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 280(20), 1998, pp. 1752-1756

Authors: BEASLEY CM SANGER T SATTERLEE W TOLLEFSON G TRAN P HAMILTON S GREEN A DOTT S PFISTER G ROXAS L SMALL J THOMAS M AMES D SCHOOLER N BAKER R LEVINE R FABRE L FRIEDEL R SAFFERMAN A LIEBERMAN J STAHL S
Citation: Cm. Beasley et al., OLANZAPINE VERSUS PLACEBO - RESULTS OF A DOUBLE-BLIND, FIXED-DOSE OLANZAPINE TRIAL, Psychopharmacology, 124(1-2), 1996, pp. 159-167

Authors: KANE JM SCHOOLER NR MARDER S WIRSHING W AMES D UMBRICHT D SAFFERMAN A BAKER R GANGULI R
Citation: Jm. Kane et al., EFFICACY OF CLOZAPINE VERSUS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL, Schizophrenia research, 18(2-3), 1996, pp. 9-9

Authors: SZYMANSKI S LIEBERMAN J POLLACK S KANE JM SAFFERMAN A MUNNE R UMBRICHT D WOERNER M MASIAR S KRONIG M
Citation: S. Szymanski et al., GENDER DIFFERENCES IN NEUROLEPTIC NONRESPONSIVE CLOZAPINE-TREATED SCHIZOPHRENICS, Biological psychiatry, 39(4), 1996, pp. 249-254

Authors: SCHOOLER N KANE J MARDER S BAKER R SAFFERMAN A WIRSHING W AMES D GANGULI R UMBRICHT D BORENSTEIN M
Citation: N. Schooler et al., EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY FINDINGS, Schizophrenia research, 15(1-2), 1995, pp. 165-165

Authors: AMES D WIRSHING WC KANE J SCHOOLER N MARDER SR BAKER R SAFFERMAN A GANGULI R UMBRICHT D BORENSTEIN M
Citation: D. Ames et al., EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY-RESULTS, Biological psychiatry, 37(9), 1995, pp. 661-661

Authors: SZYMANSKI S LIEBERMAN J POLLACK S SAFFERMAN A MUNNE R UMBRICHT D KANE J KRONIG M CHAKOS M COOPER T
Citation: S. Szymanski et al., CLOZAPINE EFFECTS ON NEUROENDOCRINE RESPONSE TO APOMORPHINE CHALLENGETESTING IN CHRONIC NEUROLEPTIC NONRESPONSIVE SCHIZOPHRENIA - PRELIMINARY FINDINGS, Biological psychiatry, 37(1), 1995, pp. 52-55

Authors: BAILINE SH SAFFERMAN A VITALHERNE J BERNSTEIN S
Citation: Sh. Bailine et al., FLUMAZENIL REVERSAL OF BENZODIAZEPINE-INDUCED SEDATION FOR A PATIENT WITH SEVERE PRE-ECT ANXIETY, Convulsive therapy, 10(1), 1994, pp. 65-68

Authors: ARONOWITZ J WU H POLLACK S BILDER R KANE J SAFFERMAN A LIEBERMAN J
Citation: J. Aronowitz et al., CLOZAPINE RESPONSE IN CHRONIC-SCHIZOPHRENIA NOT ASSOCIATED WITH BRAINMORPHOLOGY ON MRI - A PRELIMINARY-REPORT, Biological psychiatry, 35(9), 1994, pp. 742-742

Authors: SZYMANSKI S LIEBERMAN J POLLACK S MUNNE R SAFFERMAN A KANE J KRONIG M COOPER T
Citation: S. Szymanski et al., THE DOPAMINE-SEROTONIN RELATIONSHIP IN CLOZAPINE RESPONSE, Psychopharmacology, 112(1), 1993, pp. 190000085-190000089

Authors: SZYMANSKI S LIEBERMAN JA SAFFERMAN A GALKOWSKI B
Citation: S. Szymanski et al., RIB FRACTURES AS AN UNUSUAL COMPLICATION OF SEVERE TARDIVE DYSTONIA, The Journal of clinical psychiatry, 54(4), 1993, pp. 160-160

Authors: SZYMANSKI S LIEBERMAN J POLLACK S SAFFERMAN A MUNNE R
Citation: S. Szymanski et al., NEUROENDOCRINE RESPONSE TO APOMORPHINE CHALLENGE IN CLOZAPINE TREATEDSCHIZOPHRENICS, Biological psychiatry, 33(6A), 1993, pp. 59-59
Risultati: 1-12 |